Biotech Values

[rwdm]

In the Copaxone appellate court document the amino acid content of generic glatiramer acetate of both Momenta and Mylan are mentioned on Page 18. The numbers are quite different, especially in the case of Tyrosine (8.3% vs. 9.2% respectively which is a ~10% deviation). Does this mean that the similarity required by the FDA has some flexibilities?